Skip to Main Content
TABLE 3

Semen Analysis Parameters After Discontinuation of Therapy for Gender Dysphoria

PatientGender-Affirming TherapySemen Parameters
Leuprolide Acetate, mg per 28 dSpironolactone, mg per dEstradiol, μg per dAge of Initiation, yDuration of Therapy, moDuration of Therapy Discontinuation, moVolume, mLDensity (per mL), SpermMotility, %Morphology, %No. Sperm Cryopreserved
15 N/A N/A 17.5 12 16.6 N/A 12 
      73 million  56 146 million 
N/A 100 75 18 26 2.5 N/A N/A 
      1.5 N/A N/A 
      1.7 N/A N/A 
PatientGender-Affirming TherapySemen Parameters
Leuprolide Acetate, mg per 28 dSpironolactone, mg per dEstradiol, μg per dAge of Initiation, yDuration of Therapy, moDuration of Therapy Discontinuation, moVolume, mLDensity (per mL), SpermMotility, %Morphology, %No. Sperm Cryopreserved
15 N/A N/A 17.5 12 16.6 N/A 12 
      73 million  56 146 million 
N/A 100 75 18 26 2.5 N/A N/A 
      1.5 N/A N/A 
      1.7 N/A N/A 

N/A, not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal